← Back to Search

Behavioural Intervention

Anxiety Intervention for Cancer Patients and Caregivers

N/A
Recruiting
Led By Kelly McConnell, PhD
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Summary

"This trial aims to determine if an anxiety treatment program is both feasible and helpful for Latino older adults with cancer and their caregivers."

Who is the study for?
This trial is for Latino older adults with cancer and their caregivers. It aims to see if an anxiety treatment program can help them.Check my eligibility
What is being tested?
The intervention being studied is the Managing Anxiety from Cancer (MAC) program, designed to reduce anxiety in Latino older adults with cancer and their caregivers.See study design
What are the potential side effects?
Since this trial involves a non-medical intervention focused on managing anxiety, there are no direct medical side effects expected.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
percentage of participants to complete all study procedures

Trial Design

1Treatment groups
Experimental Treatment
Group I: Latino caregivers and the Latino older adults with cancer (OACs)Experimental Treatment1 Intervention
The intervention, MAC, is a seven-session (45- 60 minutes per session) psychotherapy intervention delivered via videoconference and/or telephone by licensed social workers. All sessions will be audio-recorded. MAC content, structure, and length are consistent with core components of cognitive behavioral therapy (CBT) (Freeman, 2004).

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor
1,944 Previous Clinical Trials
589,691 Total Patients Enrolled
Kelly McConnell, PhDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
2 Previous Clinical Trials
178 Total Patients Enrolled
~40 spots leftby Mar 2026